Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

0,5 mg Fingolimod

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[1] 13 💬

FINGOLIMOD

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[3] 13, 14, 156 💬

Fingolimod (FTY720)

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[2] 13, 156 💬

Fingolimod 0.5 mg

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[1] 13 💬

Fingolimod 0.5mg

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[1] 13 💬

Fingolimod 1.25 mg

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[1] 13 💬

FINGOLIMOD HYDROCHLORIDE

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[2] 13, 14 💬

Fingolimodi

[1] 13 💬

Gilenya hard capsulesProduct Name: FingolimodPharmaceutical Form: CapsuleINN or Proposed INN: FingolimodCAS Number: 162359-55-9Concentration unit: mg milligram(s)Concentration type: rangeConcentration number: 0.25-0.50Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use

[1] 13 💬

Hidrocloruro de fingolimod

[1] Fingolimod (Fingolimod lauryl sulfate)

[3] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Fingolimod (Fingolimod),
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

[1] S1PR1 💬

[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬

[2] 13, 14 💬

Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab

[12] Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod (Fingolimod lauryl sulfate),
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide

[13] Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Glatiramer acetate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod (Fingolimod),
Teriflunomide ,
Ponesimod ,
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

Name	Other Names
Cladribine	Leustatin Mavenclad
Alemtuzumab	Campath Lemtrada
Rituximab	Rituximab-abbs Rituximab-pvvr Rituximab-arrx Rituxan Riabni Truximab RUXIENCE TRUXIMA
Dimethyl fumarate	Tecfidera
Fingolimod hydrochloride	Gilenya FINGOLIMOD
Glatiramer acetate	Copaxone GLATOPA
Ocrelizumab	Ocrevus OCREVUS ZUNOVO
Natalizumab	Natalizumab-sztn Tysabri Tyruko
Ofatumumab	Arzerra Kesimpta
Fingolimod	Gilenya
Teriflunomide	Aubagio
Ponesimod	Ponvory
Fingolimod lauryl sulfate	Tascenso TASCENSO ODT

[26] DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬

Name	Full Name
DHODH	dihydroorotate dehydrogenase (quinone), mitochondrial
HLA-A	HLA class I histocompatibility antigen, A alpha chain isoform A*03:01:01:01 precursor
HLA-B	major histocompatibility complex, class I, B precursor
HLA-C	HLA class I histocompatibility antigen, C alpha chain precursor
HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain precursor
HLA-DMB	HLA class II histocompatibility antigen, DM beta chain precursor
HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain precursor
HLA-DOB	HLA class II histocompatibility antigen, DO beta chain precursor
HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain precursor
HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain precursor
HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor
HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor
HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain isoform 2 precursor
HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain precursor
HLA-DRB1	major histocompatibility complex, class II, DR beta 1 precursor
HLA-DRB3	major histocompatibility complex, class II, DR beta 3 precursor
HLA-DRB4	major histocompatibility complex, class II, DR beta 4 precursor
HLA-DRB5	major histocompatibility complex, class II, DR beta 5 precursor
HLA-E	HLA class I histocompatibility antigen, alpha chain E precursor
HLA-F	HLA class I histocompatibility antigen, alpha chain F isoform 2 precursor
HLA-G	HLA class I histocompatibility antigen, alpha chain G isoform 2 precursor
ITGA4	integrin alpha-4 isoform 1 preproprotein
KEAP1	kelch-like ECH-associated protein 1
MS4A1	B-lymphocyte antigen CD20
RRM1	ribonucleoside-diphosphate reductase large subunit isoform 1
S1PR1	sphingosine 1-phosphate receptor 1

[58] Allograft rejection, Antigen processing and presentation, Arrhythmogenic right ventricular cardiomyopathy, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Chemical carcinogenesis - reactive oxygen species, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Efferocytosis, Endocytosis, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Phagocytosis, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Ubiquitin mediated proteolysis, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬

[1] 13 💬

OcrevusPharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: OcrelizumabCAS Number: 637334-45-3Current Sponsor code: RO4964913Other descriptive name: OCRELIZUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous useTrade Name: GilenyaPharmaceutical Form: Capsule, hardINN or Proposed INN: FingolimodCAS Number: 162359-55-9Current Sponsor code: RO7079904Other descriptive name: FINGOLIMODConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 0.5-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use

[1] 13 💬

Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

[7] Acetate,
Fingolimod (Fingolimod lauryl sulfate),
Glatiramer,
Ozanimod,
Ponesimod,
Siponimod,
Teriflunomide

[10] Fingolimod hydrochloride (Fingolimod hydrochloride, FINGOLIMOD),
Glatiramer acetate ,
Fingolimod (Fingolimod),
Teriflunomide ,
Ozanimod hydrochloride ,
Ozanimod ,
Siponimod fumarate ,
Ponesimod ,
Siponimod ,
Fingolimod lauryl sulfate (Fingolimod lauryl sulfate) 💬

Name	Other Names
Fingolimod hydrochloride	Gilenya FINGOLIMOD
Glatiramer acetate	Copaxone GLATOPA
Fingolimod	Gilenya
Teriflunomide	Aubagio
Ozanimod hydrochloride	Zeposia
Ozanimod	Ozanimod
Siponimod fumarate	Siponimod fumaric acid Mayzent
Ponesimod	Ponvory
Siponimod	Siponimod
Fingolimod lauryl sulfate	Tascenso TASCENSO ODT

Name	Full Name
DHODH	dihydroorotate dehydrogenase (quinone), mitochondrial
HLA-A	HLA class I histocompatibility antigen, A alpha chain isoform A*03:01:01:01 precursor
HLA-B	major histocompatibility complex, class I, B precursor
HLA-C	HLA class I histocompatibility antigen, C alpha chain precursor
HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain precursor
HLA-DMB	HLA class II histocompatibility antigen, DM beta chain precursor
HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain precursor
HLA-DOB	HLA class II histocompatibility antigen, DO beta chain precursor
HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain precursor
HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain precursor
HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor
HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor
HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain isoform 2 precursor
HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain precursor
HLA-DRB1	major histocompatibility complex, class II, DR beta 1 precursor
HLA-DRB3	major histocompatibility complex, class II, DR beta 3 precursor
HLA-DRB4	major histocompatibility complex, class II, DR beta 4 precursor
HLA-DRB5	major histocompatibility complex, class II, DR beta 5 precursor
HLA-E	HLA class I histocompatibility antigen, alpha chain E precursor
HLA-F	HLA class I histocompatibility antigen, alpha chain F isoform 2 precursor
HLA-G	HLA class I histocompatibility antigen, alpha chain G isoform 2 precursor
S1PR1	sphingosine 1-phosphate receptor 1
S1PR2	sphingosine 1-phosphate receptor 2
S1PR3	sphingosine 1-phosphate receptor 3
S1PR4	sphingosine 1-phosphate receptor 4 precursor
S1PR5	sphingosine 1-phosphate receptor 5

[37] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬

[1] 13 💬